Pancreatic Injury in COVID-19 Patients.
Conclusion: The prevalence of hyperamylasemia in patients of COVID-19 was 33%, while that of elevated lipase was 24.1%. Pancreatic injury failed to show any statistically significant relation to severity or outcome of COVID-19.
PMID: 33247644 [PubMed - as supplied by publisher]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
More News: Coronavirus | COVID-19 | General Medicine | India Health | Outbreaks | Pancreas | Respiratory Medicine | SARS | Statistics | Study